Patents by Inventor Patrick John Kingsley

Patrick John Kingsley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4120975
    Abstract: There is described a method of treatment of certain psychiatric conditions which method comprises administration of a compound of the formula I, ##STR1## or a therapeutically acceptacle salt, ester or amide thereof, (as active ingredient), to a patient having such a condition.
    Type: Grant
    Filed: September 8, 1977
    Date of Patent: October 17, 1978
    Assignee: Fisons Limited
    Inventors: Thomas Samuel Campbell Orr, Patrick John Kingsley
  • Patent number: 4067992
    Abstract: There is described a method of treatment of certain psychiatric conditions, or of certain skin conditions, which method comprises per os administration of a compound of the formula I ##STR1## or a therapeutically acceptable salt, ester or amide thereof, wherein X is a polymethylene chain containing 3 to 7 carbon atoms inclusive, which chain may be substituted by an --OH group, (as active ingredient), to a patient having such a condition.
    Type: Grant
    Filed: August 26, 1976
    Date of Patent: January 10, 1978
    Assignee: Fisons Limited
    Inventors: Patrick John Kingsley, Thomas Samuel Campbell Orr
  • Patent number: 4029761
    Abstract: There is described a method for the treatment of gingivitis (and particularly chronic gingivitis) which comprises administering an effective quantity of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane, or a pharmaceutically acceptable salt thereof, as active ingredient, to a patient suffering from gingivitis.
    Type: Grant
    Filed: October 6, 1975
    Date of Patent: June 14, 1977
    Assignee: Fisons Limited
    Inventor: Patrick John Kingsley
  • Patent number: 3988469
    Abstract: There is described a method for the treatment of hyperuricaemia and/or gout, which comprises administering an effective quantity of 6,8-di-t-butyl-4-oxo-4H-1-benzopyran-2-carboxylic acid, or a pharmaceutically acceptable salt thereof, as active ingredient, to a patient having hyperuricaemia and/or gout. There are also described unit dosage forms of pharmaceutical compositions containing the compound.
    Type: Grant
    Filed: July 1, 1975
    Date of Patent: October 26, 1976
    Assignee: Fisons Limited
    Inventors: Thomas James Sullivan, Patrick John Kingsley